RxDoctor Payments Data

Kimberly Cudworth, APRN

Family · Harrison, ARNPI 1760155121

Payments from drug & device makers

$878in general payments, 2019–2025

Across 49 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$146
  • Bayer$138
  • Novo Nordisk$122
  • Amgen$87
  • Boehringer Ingelheim$59
  • Exact Sciences$57
  • plus $269 from 14 others

What the payments were for

  • Food & beverage$878100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$878 in reported general payments places this provider in the 65th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$40,247
Medicare patients
162
Services billed
1,944

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide19$20,137
OzempicSemaglutide19$17,944
Albuterol Sulfate HfaAlbuterol Sulfate59$1,608
Cefdinir22$685
Levothyroxine Sodium70$449
Atorvastatin Calcium59$354
Methylprednisolone57$332
Doxycycline Hyclate23$195
Ezetimibe13$157
Warfarin Sodium13$154
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide23$152
Fluticasone Propionate20$139
Hydrochlorothiazide17$137
Losartan Potassium12$135
Zolpidem Tartrate11$127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$122$17,94419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,103 family providers in Arkansas.

Other family in Harrison

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →